Back to Industry News
Medtech
Forbes: Arterya's CEO Lucile Derly Developing Medical Device
Summary generated with AI, editor-reviewed
Heartspace News Desk
•Source: Forbes
Photo by Natanael Melchor on Unsplash
TL;DR
Arterya CEO and co-founder, Lucile Derly, was included in Forbes' 2023 30 Under 30 Europe list for Science & Healthcare because her company is developing a medical device to improve arterial location accuracy. Arterya, founded in 2020, has raised $1.6 million and plans to begin clinical trials in French hospitals later this year.
Stay updated on stories like this
Key takeaways
- Lucile Derly, co-founder and CEO of Arterya, has been named to Forbes' 2023 30 Under 30 - Europe - Science & Healthcare list
- Derly's company is developing a medical device intended to improve the accuracy of arterial location during essential procedures, including blood gas testing and the placement of stents or catheters
- Since its inception in 2020, Arterya has secured $1
Lucile Derly, co-founder and CEO of Arterya, has been named to Forbes' 2023 30 Under 30 - Europe - Science & Healthcare list. Derly's company is developing a medical device intended to improve the accuracy of arterial location during essential procedures, including blood gas testing and the placement of stents or catheters.
Since its inception in 2020, Arterya has secured $1.6 million in equity and debt financing to facilitate its technological advancements. The company plans to commence clinical trials of its device in three French hospitals later this year.
Related Topics
Lucile DerlyArteryamedical device30 Under 30Forbesmedtechhealthcareinnovation
Never miss stories like this
Verified mention available
Free to claim
Is this your company?
Set up real-time alerts and keep your Heartspace News coverage accurate. Verified teams can update profiles, request corrections, and collaborate on future stories.
Set up alerts Takes under 1 minute • Verified manually